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Synthesis of N-Benzoyl-2-hydroxybenzamides as Agents Utilized in Treatment of
Malaria
After completion of the first half of this
Malaria is a disease that
disproportionately affects
several third world
countries. It is a
life-threatening illness
that is transmitted by
mosquitoes that act as
vesicles for parasites.
The disease is preventable and curable, but according to the
world health organization, countries disproportionately
affected cannot afford these preventative care measures or have
developed resistance to treatments. Doxycycline is the
antibiotic most commonly used for preventative measures and
Hydroxychloroquine is a common treatment drug, though it
has been rendered largely ineffective due to the parasite
developing a resistance to the compound.
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compound, it is clear that its production, if
proven an effective treatment for malaria, will
be more efficient and widely available. This is
largely because of the high yield of the initial
reactions (Fischer Esterification and Suzuki
Coupling) as well as the ease of purification
cutting down on costs, and making the market
value for the drug more affordable for the
disproportionately affected countries. Once the
compound is completed, different R-side chains
will be attached and testing will be conducted.
This will be accomplished by sending these
compounds to Drugs for Neglected Disease
(DNDI).
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